Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
6
×
life sciences
national blog main
san diego blog main
san diego top stories
6
×
boston blog main
boston top stories
clinical trials
new york blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
ipo
national
cancer
chronic kidney disease
crispr
glaxosmithkline
investing
medical devices
messenger rna
nonalcoholic steatohepatitis
parkinson's disease
startups
What
therapeutics
6
×
drug
ipo
million
bio
companies
company
immunotherapy
life
medicines
new
raised
roundup
science
week
agency
aimmune
allergy
allogene
approval
approved
awarded
bacteria
biopharma
biotechs
black
brings
business
cancer
club
continue
continued
crispr
crop
debut
developed
developing
diamond
diamond’s
disease
Language
unset
Current search:
fda
×
therapeutics
×
" san diego top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M